Clinical Trial Update: Virologic and Immunologic Activity of Continued Lamivudine (3TC) vs Delavirdine (DLV) in Combination With Indinavir (IDV) and Zidovudine (ZDV) or Stavudine (d4T) in 3TC-Experienced Subjects [Phase 2]

View source ↗

Summary

Phase 2 trial comparing continued lamivudine (3TC) versus delavirdine (DLV) in combination with indinavir (IDV) and either zidovudine (ZDV) or stavudine (d4T) i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Delavirdine (delavirdine)
• Indinavir (indinavir)
• Lamivudine (3TC) (lamivudine)
• Zidovudine (Zidovudine)
• stavudine (stavudine)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 2 | Status: COMPLETED